## Summary
The paper proposes a dual-metric checkpoint selection procedure for self-supervised histopathology encoders, combining out-of-distribution benchmark metrics with rank-based representation quality metrics (RankMe, LiDAR, α‑ReQ). The authors train nine Dino-based ViT/SMoE encoders on LUAD and show that mid-training checkpoints selected by their procedure generally outperform final checkpoints on multiple tile-level benchmarks and perform competitively on two held-out downstream tasks, sometimes approaching large pan-cancer foundation models on segmentation benchmarks.

## Strengths
- Substantive and well-motivated problem: model selection for SSL histopathology encoders without direct access to downstream labels, where training loss is known to be a poor proxy (§1.1, §2.2).
- Clear, fully specified selection algorithm (Algorithm 1, §3) that can in principle be applied beyond this particular setting, with explicit normalization, metric pairing, and voting steps.
- Nontrivial empirical effort: nine distinct Dino-based encoders across magnifications and capacities, including SMoE variants (Table 1), all trained >230 epochs and evaluated on three classification and three segmentation benchmarks plus two held-out clinical tasks (§4–§5.3).
- Consistent evidence that final checkpoints are often suboptimal: across models, “Final” rows in Table 2 are usually worse than selected checkpoints on multiple benchmarks, despite monotonically decreasing training loss (Figure 1), highlighting a real and underappreciated pitfall in histopathology SSL.
- Competitive performance of small, single-tissue models relative to large foundation models on segmentation tasks: on PanNuke 20× and MoNuSeg, several selected checkpoints for the authors’ models achieve AJI equal to or slightly exceeding Virchow2/UNI (Table 2, §5.2).
- Honest discussion that rank-based metrics are poor indicators of segmentation performance and limited for non-linear histopathology tasks (§2.2, §5.1, §6), which is itself a useful empirical insight.

## Weaknesses

### Fatal
None.

### Major
- **No benchmark-only selection baseline to isolate the added value of task-agnostic metrics.**  
  Algorithm 1 always combines task-specific and task-agnostic metrics, but the paper never shows what happens if one uses only benchmark trajectories (i.e., set \(M=0\) and keep the same normalization/relative-improvement machinery). As written, the results clearly support “do not use the final epoch; pick an early checkpoint based on OOD benchmarks” (Table 2, Figure 2), but the central thesis that *adding* RankMe/LiDAR/α‑ReQ improves checkpoint selection over benchmark-only heuristics is not empirically demonstrated. The authors themselves note that “representation ranks are poor indicators of segmentation performance” (§5.1, lines 148–149). Without a clean ablation, it is plausible that similar or identical checkpoints could be obtained from benchmark metrics alone, weakening the methodological novelty.

- **Causal attribution of “small models match large foundation models” to the selection procedure is not substantiated.**  
  Table 2 makes clear that Virchow, Virchow2, and UNI are evaluated as single “Reference” rows with their reported checkpoints, whereas the proposed selection algorithm is applied only to the authors’ own models. The text states that “these external models were also benchmarked using the procedures described in Appendix B” (§4, line 140), but there is no indication that alternative checkpoints for those models were explored, nor that the same dual-metric procedure was applied to their training trajectories. As a result, when §5.2–§6 claim that small single-tissue models “often achieve comparable performance” and “frequently outperform the foundation models” (lines 172–173, 237–238, 310–311), the contribution of the *selection method* cannot be disentangled from architectural/training differences or from simply comparing “our best checkpoint” to “their default checkpoint”. This over-attributes the performance gap to the proposed procedure.

- **Overstated generality of the “training longer is detrimental” conclusion.**  
  The paper concludes that “training histopathology models for arbitrarily large number of training epochs is actually detrimental to its downstream performance” and frames this as in “sharp contrast” to other modalities (§5.2 lines 170–171; §6 lines 310–312). However, the evidence is limited to nine Dino-v1-based models, a single LUAD dataset, and a single training pipeline without variations in SSL objective, regularization, or data augmentation. Performance differences between best and final checkpoints, while consistent in sign, are often modest (e.g., PanNuke AJI 0.47 vs 0.44, MHIST 0.85 vs 0.80 in Table 2), and only single runs per configuration are reported. The empirical findings do support that *for these LUAD Dino-v1 models* mid-training checkpoints tend to be better than final ones, but not the much broader negative statement about “training for arbitrarily large number of epochs” in histopathology SSL in general.

### Minor
- **Role and benefit of rank-based metrics remain under-analyzed and under-quantified.**  
  The paper qualitatively notes alignment of RankMe/LiDAR/α‑ReQ with some classification tasks and their failure for segmentation (Figures 2–3, §5.1), but provides no quantitative correlation analysis (e.g., Spearman correlations between each rank metric and each benchmark across epochs) and no ablation of each metric’s contribution to checkpoint choice. Since the authors themselves stress that rank metrics are limited for non-linear tasks and that their method “builds a bridge” between benchmarks and representation metrics (§1.1, §2.2), these quantitative diagnostics would solidify whether the rank terms are helpful, neutral, or mostly adding noise.

- **Definitions and empirical distinction between “classification-best,” “segmentation-best,” and “all-round” checkpoints could be clearer.**  
  Algorithm 1 outputs a single epoch \(e^*\), and §3 later states that “three separate model selections are made: \(e_a^*, e_c^*, e_s^*\)” (lines 108–109), but the main text never precisely spells out how the metric sets \(U_i, V_j\) differ across these three variants (e.g., whether segmentation-best entirely excludes classification tasks in the relative-improvement step). Table 2 encodes different checkpoint types via multiple “\(e_n^*\)” rows, but without explicit mapping in the text, readers must infer which row corresponds to which selection criterion. This affects interpretability of Figure 4 and of the claim that users can pick a checkpoint “based on the type of downstream task.”

- **Lack of uncertainty estimates or multiple runs limits confidence in small reported gains.**  
  All benchmark and downstream results appear to be from single runs per encoder, with no repeated seeds or cross-validation beyond the 10 splits aggregated for EGFR (§5.3 lines 291–292). Many of the differences highlighted—e.g., 0.01–0.03 AJI/F1 differences between checkpoints or versus foundation models—could plausibly be within run-to-run variability. Confidence intervals or repeated experiments for at least a subset of models and tasks would strengthen claims about consistent superiority of selected checkpoints and their relative position to large baselines.

- **Scope/claims around “obtaining a model based on the type of downstream task” are somewhat stronger than the evidence.**  
  The abstract and introduction claim that the approach “allows for obtaining a model based on the type of downstream task” (Abstract; §1.2 lines 35–38). Figure 4 and §5.3 show that, for some models, different checkpoint types perform similarly and that performance differences across \(e_a^*, e_s^*, e_c^*\) are modest; in several cases, there is no clearly superior type for a given downstream task. This is suggestive and practically useful, but not a strong validation that segmentation-best consistently dominates on segmentation-like tasks and classification-best on classification tasks.

### Trivial
- Some aspects of Algorithm 1’s description could be more explicit (e.g., an explicit formula for “relative improvement” and the precise handling of α‑ReQ’s special treatment in the main text rather than only via footnote 4), but these are presentation details rather than scientific flaws.

## Nice-to-Haves
- Include a benchmark-only selection baseline (same normalization and relative-improvement scheme but \(M=0\)) and, ideally, a simple “max mean benchmark” baseline, to directly test whether dual metrics improve checkpoint choice.
- Provide quantitative correlation plots or tables between each rank metric and each benchmark metric over epochs, to formally support the observed alignment/misalignment patterns in Figures 2–3.
- Add ablations using only RankMe, only LiDAR, and only α‑ReQ in Algorithm 1 (or dropping them entirely) to clarify whether any of them yields systematically different or better checkpoint choices.
- For at least one foundation model, attempt to apply an analogous checkpoint-selection procedure (or discuss why it is infeasible) to make the “small vs large” comparison more symmetric.
- Explore another SSL objective (e.g., a dinov2- or MAE-style variant) or another tissue type to check whether the “mid-training is best” phenomenon persists, thereby making the “training longer can be detrimental” statement more nuanced and general.

## Removed Points
These points are flagged to be removed; treat them with caution.

- **Claim that the paper fails to position itself with respect to where rank metrics are known to work vs not.**  
  The main text already acknowledges that prior rank metrics have been tested on linear probing and that their reliance on linear behavior may be inadequate for non-linear tasks such as MIL and segmentation (§1.1 lines 29–31; §2.2 lines 67–69). Criticizing the related work for not making this contrast is redundant with what is present in the paper.

- **Criticisms about missing or opaque implementation minutiae (e.g., exact checkpoint saving frequency, all hyperparameters, appendix details).**  
  The authors state checkpoints are saved every few epochs (implicitly in §3, §4) and defer full procedures to appendices (which we know are stripped in this parse). Per instructions, such reproducibility nitpicks focused on absent appendices or minor details are removed.

- **Complaints that Virchow/Virchow2/UNI may be “not yet released” or otherwise unavailable for verification.**  
  The paper clearly treats these as existing external baselines (§4, Table 1), and per policy, availability concerns about cited models/datasets are not valid weaknesses here.

## Novel Insights
The main genuinely new takeaways relative to standard SSL practice are: (i) for Dino-v1 histopathology encoders trained on LUAD, mid-training checkpoints systematically outperform final ones on a range of out-of-distribution benchmarks and held-out tasks despite monotonically decreasing training loss; and (ii) rank-based representation metrics, while somewhat aligned with classification benchmarks, are notably poor guides for instance segmentation performance, underscoring that such metrics cannot be assumed to generalize from linear probing in natural images to more complex histopathology tasks without empirical validation.

## Suggestions
- Reframe the paper’s core claim to emphasize the strong empirical evidence about early/mid-epoch superiority and the limitations of rank metrics for segmentation, rather than asserting that the specific dual-metric procedure is uniquely effective.
- Add a benchmark-only selection baseline and simple alternatives (e.g., max mean benchmark performance) using exactly the same candidate set and relative-improvement voting to determine whether RankMe/LiDAR/α‑ReQ meaningfully change checkpoint choices.
- Clarify in §3 how \(e_c^*, e_s^*, e_a^*\) are derived from Algorithm 1 by explicitly specifying the subsets of benchmarks \(U\) used in each variant, and directly annotate Table 2 rows with these labels.
- Temper claims about “training longer is detrimental” by restricting them to the studied setting and acknowledging that different SSL objectives, tissues, or regularization might alter the trend.
- Where small margins versus foundation models are highlighted (e.g., AJI 0.47 vs 0.48–0.49), either provide variance estimates or clearly phrase these as “comparable” rather than “often outperform,” especially when differences are ≤0.02.

On standard axes: the work is reasonably original (novel empirical angle on model selection in histopathology SSL, though the algorithmic novelty is modest), addresses an important practical question, and provides solid but not fully exhaustive empirical support. Experiments are sound for the main empirical observations but incomplete for the strongest methodological claims. Writing is generally clear, and the paper has real value to the pathology and SSL communities, albeit more as an empirical/observational study than as a definitive new method.

## Score and Decision

### Calibration anchors consulted
- **High-score anchors (>7):**
  - `/home/wg25r/review_agent/human_reviews/rFpZnn11gj.md` (avg 7.5, Accept Oral): pathology image-text SSL with strong, well-validated gains and thorough ablations. Compared to this, the current paper has weaker methodological validation (no clean baseline isolating the dual-metric benefit) and narrower scope.
  - `/home/wg25r/review_agent/human_reviews/otHZ8JAIgh.md` (avg 7.25, Accept spotlight): strong histopathology WSI modeling paper with comprehensive experiments and careful causal claims. The paper under review has less robust statistics and more overclaiming.
  - `/home/wg25r/review_agent/human_reviews/rzBskAEmoc.md` (avg 7.5, Accept spotlight): WSI pathology model with very strong empirical evidence and well-supported claims about model selection; clearly stronger than the present work on experimental rigor.
  - `/home/wg25r/review_agent/human_reviews/LUpC8KTvdV.md` (avg 7.0, Accept poster): SSL method with solid ablations and clear improvement over baselines; again somewhat more thorough than this submission.

- **Medium-score anchors (4–6):**
  - `/home/wg25r/review_agent/human_reviews/j9dDXNffBz.md` (avg 5.0, rejected): dual-metric HPO/model selection with some interesting ideas but lacking decisive ablations—conceptually similar strength/weakness pattern to this paper.
  - `/home/wg25r/review_agent/human_reviews/Zihqr7qqpg.md` (avg 4.67, rejected): work on early-stopping criteria where overclaiming and missing baselines undermined impact.
  - `/home/wg25r/review_agent/human_reviews/qAoxvePSlq.md` (avg 5.75, accepted poster): selection-style method with decent but not overwhelming gains and some missing analyses.
  - `/home/wg25r/review_agent/human_reviews/3Mq1tY75nv.md` (avg 5.75, rejected): representation-metric paper that overstates claims with partial empirical support—similar in that the metrics’ benefits are under-verified.
  - `/home/wg25r/review_agent/human_reviews/jUNSBetmAo.md` (avg 5.25, rejected) and `/home/wg25r/review_agent/human_reviews/5IOKw3AQe4.md` (avg 6.0, rejected): both on representation evaluation with interesting ideas but insufficient empirical rigor.

- **Low-score anchors (<3):**
  - `/home/wg25r/review_agent/human_reviews/ywD00GsxgD.md` (avg 2.6, Reject): model-selection via synthetic validation with serious methodological flaws and weak experiments.
  - `/home/wg25r/review_agent/human_reviews/cHy00K3Och.md` (avg 2.5, Reject): subset/coreset selection paper with poor empirical support.
  - `/home/wg25r/review_agent/human_reviews/EOPLy80bBm.md` (avg 3.0, Withdrawn): selection in data pruning with significant conceptual and empirical gaps.
  - `/home/wg25r/review_agent/human_reviews/An87ZnPbkT.md` (avg 3.0, Reject) and `/home/wg25r/review_agent/human_reviews/FaL6aTuXod.md` (avg 1.5, Withdrawn): algorithm/benchmarking selection works with major problems.

Relative to these anchors, the current paper is clearly above the low band: its empirical work is coherent and the findings are believable. It is roughly on par with the stronger medium-band selection/representation-metric papers (e.g., j9dDXNffBz, 3Mq1tY75nv, 5IOKw3AQe4) but below the high-band histopathology and SSL anchors in terms of rigor and strength of support for its main methodological claim. The lack of a benchmark-only baseline and the over-general “training longer is detrimental” narrative keep it from the 7+ range.

Balancing solid empirical observations and useful insights against these methodological limitations and overclaims, an overall score around the mid-5 range (borderline, interesting but not yet fully convincing as a method paper) is appropriate.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>